Position in FLGT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,060,842
+$165,529 QoQ
Shares Held
51,698
-8.2% QoQ
Ownership
0.188%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#48
of 142 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in FLGT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $9,382,081 across 8 Diagnostics & Research names. FLGT ranks #3 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SHC |
Sotera Health Co
|
208,430 | $3,699,632 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
5,752 | $2,883,822 | |
| 3 | FLGT |
Fulgent Genetics, Inc.
This page
|
51,698 | $1,060,842 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
809 | $425,889 | |
| 5 | DHR |
Danaher Corp /De/
|
2,072 | $394,674 | |
| 6 | NTRA |
Natera, Inc.
|
1,428 | $387,630 | |
| 7 | LH |
Labcorp Holdings Inc.
|
1,130 | $316,400 | |
| 8 | GH |
Guardant Health, Inc.
|
1,421 | $213,192 |
All Filings in FLGT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,060,842 | 51,698 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $895,313 | 56,309 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $985,019 | 37,496 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,563,761 | 69,193 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,370,944 | 68,961 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,416,405 | 83,811 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $285,232 | 15,443 | Shares | Other | 2025-02-14 | |
| 2020-03-31 | $10,135 | 942 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||